title: Influence of capecitabine absorption on its metabolites pharmacokinetics: a bioequivalence study.
authors.forename: L
authors.initials: L
authors.lastname: Chaigneau
authors.forename: B
authors.initials: B
authors.lastname: Royer
authors.forename: D
authors.initials: D
authors.lastname: Montange
authors.forename: T
authors.initials: T
authors.lastname: Nguyen
authors.forename: T
authors.initials: T
authors.lastname: Maurina
authors.forename: C
authors.initials: C
authors.lastname: Villanueva
authors.forename: M
authors.initials: M
authors.lastname: Demarchi
authors.forename: C
authors.initials: C
authors.lastname: Borg
authors.forename: C
authors.initials: C
authors.lastname: Fagnoni-Legat
authors.forename: J-P
authors.initials: JP
authors.lastname: Kantelip
authors.forename: X
authors.initials: X
authors.lastname: Pivot
mesh_terms: D000042:Absorption; D000284:Administration, Oral; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000493:pharmacokinetics*; D000069287:Capecitabine; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D005472:Fluorouracil / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D013607:Tablets; D013810:Therapeutic Equivalency
chemical_list: D000964:Antimetabolites, Antineoplastic; D013607:Tablets; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil